nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—SLC6A2—autonomic nervous system—conduct disorder	0.0577	0.264	CbGeAlD
Ketamine—DRD2—Dopamine receptors—DRD4—conduct disorder	0.0442	0.0566	CbGpPWpGaD
Ketamine—GRIN2C—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.0328	0.042	CbGpPWpGaD
Ketamine—GRIN2D—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.0305	0.039	CbGpPWpGaD
Ketamine—GRIN2A—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.025	0.032	CbGpPWpGaD
Ketamine—GRIN1—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.0218	0.0279	CbGpPWpGaD
Ketamine—GRIN2B—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.0213	0.0272	CbGpPWpGaD
Ketamine—GRIN2C—brain—conduct disorder	0.0182	0.0829	CbGeAlD
Ketamine—GRIN2D—brain—conduct disorder	0.0169	0.077	CbGeAlD
Ketamine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0168	0.0216	CbGpPWpGaD
Ketamine—GRIN3A—brain—conduct disorder	0.0159	0.0724	CbGeAlD
Ketamine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0157	0.0201	CbGpPWpGaD
Ketamine—GRIN1—brain—conduct disorder	0.015	0.0687	CbGeAlD
Ketamine—SLC6A2—Monoamine Transport—SLC6A4—conduct disorder	0.015	0.0192	CbGpPWpGaD
Ketamine—GRIN2B—brain—conduct disorder	0.0144	0.0655	CbGeAlD
Ketamine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.014	0.018	CbGpPWpGaD
Ketamine—TACR1—brain—conduct disorder	0.0138	0.0628	CbGeAlD
Ketamine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0129	0.0165	CbGpPWpGaD
Ketamine—GRIN2C—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0127	0.0162	CbGpPWpGaD
Ketamine—GRIN2A—brain—conduct disorder	0.0125	0.0572	CbGeAlD
Ketamine—GRIN2D—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0118	0.0151	CbGpPWpGaD
Ketamine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0112	0.0144	CbGpPWpGaD
Ketamine—OPRD1—brain—conduct disorder	0.0112	0.051	CbGeAlD
Ketamine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0109	0.014	CbGpPWpGaD
Ketamine—OPRK1—brain—conduct disorder	0.0107	0.0489	CbGeAlD
Ketamine—DRD2—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.01	0.0128	CbGpPWpGaD
Ketamine—DRD2—Monoamine GPCRs—DRD4—conduct disorder	0.00977	0.0125	CbGpPWpGaD
Ketamine—GRIN2C—Neuronal System—GABRA2—conduct disorder	0.0097	0.0124	CbGpPWpGaD
Ketamine—GRIN2A—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00967	0.0124	CbGpPWpGaD
Ketamine—TACR1—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00948	0.0121	CbGpPWpGaD
Ketamine—TACR1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00911	0.0117	CbGpPWpGaD
Ketamine—GRIN2D—Neuronal System—GABRA2—conduct disorder	0.00902	0.0116	CbGpPWpGaD
Ketamine—GRIN1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00843	0.0108	CbGpPWpGaD
Ketamine—GRIN2B—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00822	0.0105	CbGpPWpGaD
Ketamine—DRD2—Amine ligand-binding receptors—DRD4—conduct disorder	0.00821	0.0105	CbGpPWpGaD
Ketamine—OPRM1—brain—conduct disorder	0.00763	0.0348	CbGeAlD
Ketamine—GRIN2A—Neuronal System—GABRA2—conduct disorder	0.00741	0.00949	CbGpPWpGaD
Ketamine—TACR1—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00713	0.00913	CbGpPWpGaD
Ketamine—TACR1—GPCR ligand binding—CGA—conduct disorder	0.00694	0.00889	CbGpPWpGaD
Ketamine—GRIN1—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00653	0.00837	CbGpPWpGaD
Ketamine—GRIN1—Neuronal System—GABRA2—conduct disorder	0.00646	0.00828	CbGpPWpGaD
Ketamine—DRD2—Monoamine GPCRs—HTR2A—conduct disorder	0.00637	0.00816	CbGpPWpGaD
Ketamine—GRIN2B—Neuronal System—GABRA2—conduct disorder	0.0063	0.00807	CbGpPWpGaD
Ketamine—GRIN2C—Transmission across Chemical Synapses—COMT—conduct disorder	0.0061	0.00781	CbGpPWpGaD
Ketamine—GRIN2C—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00605	0.00775	CbGpPWpGaD
Ketamine—TACR1—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00581	0.00744	CbGpPWpGaD
Ketamine—GRIN2D—Transmission across Chemical Synapses—COMT—conduct disorder	0.00567	0.00726	CbGpPWpGaD
Ketamine—GRIN2D—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00563	0.00721	CbGpPWpGaD
Ketamine—SLC6A2—brain—conduct disorder	0.00558	0.0255	CbGeAlD
Ketamine—DRD2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00536	0.00686	CbGpPWpGaD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00513	0.00657	CbGpPWpGaD
Ketamine—TACR1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.0051	0.00654	CbGpPWpGaD
Ketamine—DRD2—brain—conduct disorder	0.00509	0.0232	CbGeAlD
Ketamine—TACR1—G alpha (q) signalling events—HTR2A—conduct disorder	0.00503	0.00644	CbGpPWpGaD
Ketamine—GRIN1—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00492	0.0063	CbGpPWpGaD
Ketamine—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.00488	0.00624	CbGpPWpGaD
Ketamine—GRIN2C—Neuronal System—COMT—conduct disorder	0.00467	0.00598	CbGpPWpGaD
Ketamine—GRIN2A—Transmission across Chemical Synapses—COMT—conduct disorder	0.00465	0.00596	CbGpPWpGaD
Ketamine—GRIN2C—Neuronal System—MAOA—conduct disorder	0.00464	0.00594	CbGpPWpGaD
Ketamine—GRIN2A—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00462	0.00592	CbGpPWpGaD
Ketamine—CYP2C8—brain—conduct disorder	0.00459	0.0209	CbGeAlD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0045	0.00577	CbGpPWpGaD
Ketamine—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.0045	0.00576	CbGpPWpGaD
Ketamine—SLC6A2—NRF2 pathway—SLC6A4—conduct disorder	0.00444	0.00569	CbGpPWpGaD
Ketamine—GRIN2D—Neuronal System—COMT—conduct disorder	0.00434	0.00556	CbGpPWpGaD
Ketamine—PTGS1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00432	0.00553	CbGpPWpGaD
Ketamine—GRIN2D—Neuronal System—MAOA—conduct disorder	0.00431	0.00552	CbGpPWpGaD
Ketamine—CYP2B6—brain—conduct disorder	0.00411	0.0188	CbGeAlD
Ketamine—GRIN1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00406	0.0052	CbGpPWpGaD
Ketamine—GRIN1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00403	0.00516	CbGpPWpGaD
Ketamine—GRIN1—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00401	0.00513	CbGpPWpGaD
Ketamine—GRIN2B—Transmission across Chemical Synapses—COMT—conduct disorder	0.00396	0.00507	CbGpPWpGaD
Ketamine—GRIN2B—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00393	0.00503	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—CGA—conduct disorder	0.00392	0.00502	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—CGA—conduct disorder	0.00391	0.00501	CbGpPWpGaD
Ketamine—TACR1—GPCR ligand binding—DRD4—conduct disorder	0.00389	0.00498	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0038	0.00487	CbGpPWpGaD
Ketamine—PTGS1—brain—conduct disorder	0.00372	0.017	CbGeAlD
Ketamine—OPRD1—G alpha (i) signalling events—DRD4—conduct disorder	0.00362	0.00463	CbGpPWpGaD
Ketamine—GRIN2A—Neuronal System—COMT—conduct disorder	0.00357	0.00457	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—CGA—conduct disorder	0.00356	0.00456	CbGpPWpGaD
Ketamine—GRIN2A—Neuronal System—MAOA—conduct disorder	0.00354	0.00453	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—CGA—conduct disorder	0.00343	0.00439	CbGpPWpGaD
Ketamine—OPRD1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00336	0.0043	CbGpPWpGaD
Ketamine—TACR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00333	0.00427	CbGpPWpGaD
Ketamine—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0033	0.00422	CbGpPWpGaD
Ketamine—OPRK1—G alpha (i) signalling events—DRD4—conduct disorder	0.00317	0.00406	CbGpPWpGaD
Ketamine—GRIN1—Neuronal System—COMT—conduct disorder	0.00311	0.00398	CbGpPWpGaD
Ketamine—GRIN1—Neuronal System—MAOA—conduct disorder	0.00309	0.00395	CbGpPWpGaD
Ketamine—TACR1—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00308	0.00394	CbGpPWpGaD
Ketamine—GRIN2B—Neuronal System—COMT—conduct disorder	0.00303	0.00388	CbGpPWpGaD
Ketamine—GRIN2B—Neuronal System—MAOA—conduct disorder	0.00301	0.00386	CbGpPWpGaD
Ketamine—OPRK1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00294	0.00377	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—CGA—conduct disorder	0.0029	0.00371	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00288	0.00369	CbGpPWpGaD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00288	0.00368	CbGpPWpGaD
Ketamine—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00279	0.00357	CbGpPWpGaD
Ketamine—OPRM1—G alpha (i) signalling events—DRD4—conduct disorder	0.00268	0.00343	CbGpPWpGaD
Ketamine—TACR1—GPCR ligand binding—HTR2A—conduct disorder	0.00254	0.00325	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00252	0.00323	CbGpPWpGaD
Ketamine—OPRM1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00249	0.00318	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—SLC6A4—conduct disorder	0.00245	0.00313	CbGpPWpGaD
Ketamine—PTGS1—Biological oxidations—COMT—conduct disorder	0.00231	0.00296	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—DRD4—conduct disorder	0.0023	0.00295	CbGpPWpGaD
Ketamine—PTGS1—Biological oxidations—MAOA—conduct disorder	0.0023	0.00294	CbGpPWpGaD
Ketamine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00227	0.00291	CbGpPWpGaD
Ketamine—SLC6A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00224	0.00287	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—CGA—conduct disorder	0.00221	0.00283	CbGpPWpGaD
Ketamine—ABCB1—brain—conduct disorder	0.0022	0.01	CbGeAlD
Ketamine—TACR1—GPCR downstream signaling—DRD4—conduct disorder	0.0022	0.00281	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—CGA—conduct disorder	0.0022	0.00281	CbGpPWpGaD
Ketamine—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00219	0.0028	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—DRD4—conduct disorder	0.00219	0.0028	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00213	0.00273	CbGpPWpGaD
Ketamine—GRIN1—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00212	0.00272	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CGA—conduct disorder	0.0021	0.00269	CbGpPWpGaD
Ketamine—DRD2—G alpha (i) signalling events—DRD4—conduct disorder	0.00203	0.0026	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—CGA—conduct disorder	0.00201	0.00257	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—DRD4—conduct disorder	0.00199	0.00255	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00197	0.00252	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—CGA—conduct disorder	0.00194	0.00248	CbGpPWpGaD
Ketamine—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00192	0.00246	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—DRD4—conduct disorder	0.00192	0.00246	CbGpPWpGaD
Ketamine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00188	0.00241	CbGpPWpGaD
Ketamine—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00188	0.0024	CbGpPWpGaD
Ketamine—CYP2B6—Biological oxidations—COMT—conduct disorder	0.00176	0.00226	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—CGA—conduct disorder	0.00176	0.00225	CbGpPWpGaD
Ketamine—CYP2B6—Biological oxidations—MAOA—conduct disorder	0.00175	0.00224	CbGpPWpGaD
Ketamine—CYP2B6—Metapathway biotransformation—COMT—conduct disorder	0.00174	0.00223	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—WASF1—conduct disorder	0.00169	0.00216	CbGpPWpGaD
Ketamine—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00164	0.00211	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—CGA—conduct disorder	0.00164	0.0021	CbGpPWpGaD
Ketamine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00162	0.00208	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—DRD4—conduct disorder	0.00162	0.00208	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00161	0.00207	CbGpPWpGaD
Ketamine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0015	0.00192	CbGpPWpGaD
Ketamine—CYP2C8—Biological oxidations—COMT—conduct disorder	0.00149	0.00191	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—CGA—conduct disorder	0.00149	0.0019	CbGpPWpGaD
Ketamine—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.00148	0.0019	CbGpPWpGaD
Ketamine—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.00147	0.00189	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—HTR2A—conduct disorder	0.00143	0.00184	CbGpPWpGaD
Ketamine—OPRD1—GPCR ligand binding—HTR2A—conduct disorder	0.00143	0.00183	CbGpPWpGaD
Ketamine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00139	0.00178	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—HTR2A—conduct disorder	0.0013	0.00167	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00127	0.00163	CbGpPWpGaD
Ketamine—OPRK1—GPCR ligand binding—HTR2A—conduct disorder	0.00125	0.0016	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.00124	0.00159	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—DRD4—conduct disorder	0.00124	0.00158	CbGpPWpGaD
Ketamine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00123	0.00157	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.00123	0.00157	CbGpPWpGaD
Ketamine—CYP2C9—Biological oxidations—COMT—conduct disorder	0.00122	0.00156	CbGpPWpGaD
Ketamine—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.00121	0.00155	CbGpPWpGaD
Ketamine—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.0012	0.00154	CbGpPWpGaD
Ketamine—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.0012	0.00153	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CGA—conduct disorder	0.00119	0.00152	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—DRD4—conduct disorder	0.00118	0.00151	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CGA—conduct disorder	0.00113	0.00144	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—DRD4—conduct disorder	0.00112	0.00144	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—DRD4—conduct disorder	0.00108	0.00139	CbGpPWpGaD
Ketamine—OPRM1—GPCR ligand binding—HTR2A—conduct disorder	0.00106	0.00136	CbGpPWpGaD
Ketamine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00105	0.00135	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CGA—conduct disorder	0.00104	0.00133	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00103	0.00132	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000987	0.00126	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—DRD4—conduct disorder	0.000985	0.00126	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—WASF1—conduct disorder	0.00095	0.00122	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—DRD4—conduct disorder	0.000917	0.00117	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CGA—conduct disorder	0.000878	0.00112	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—CGA—conduct disorder	0.000876	0.00112	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—EP300—conduct disorder	0.000844	0.00108	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—WASF1—conduct disorder	0.000833	0.00107	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—DRD4—conduct disorder	0.000833	0.00107	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—EP300—conduct disorder	0.000823	0.00105	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—HTR2A—conduct disorder	0.000807	0.00103	CbGpPWpGaD
Ketamine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	0.000802	0.00103	CbGpPWpGaD
Ketamine—CYP3A4—Biological oxidations—COMT—conduct disorder	0.000801	0.00103	CbGpPWpGaD
Ketamine—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.000796	0.00102	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—EP300—conduct disorder	0.000796	0.00102	CbGpPWpGaD
Ketamine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00079	0.00101	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—HTR2A—conduct disorder	0.000769	0.000985	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—HTR2A—conduct disorder	0.000733	0.000939	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—HTR2A—conduct disorder	0.000708	0.000906	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—WASF1—conduct disorder	0.000704	0.000901	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	0.000695	0.00089	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CGA—conduct disorder	0.000668	0.000856	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CGA—conduct disorder	0.000666	0.000852	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—DRD4—conduct disorder	0.000664	0.00085	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—HTR2A—conduct disorder	0.000643	0.000823	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—DRD4—conduct disorder	0.000631	0.000808	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—HTR2A—conduct disorder	0.000598	0.000766	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—DRD4—conduct disorder	0.000582	0.000745	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CGA—conduct disorder	0.000566	0.000724	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—HTR2A—conduct disorder	0.000543	0.000696	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—WASF1—conduct disorder	0.000533	0.000683	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000513	0.000657	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CGA—conduct disorder	0.000493	0.000631	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—DRD4—conduct disorder	0.000492	0.00063	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CGA—conduct disorder	0.00046	0.00059	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	0.000453	0.000581	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—HTR2A—conduct disorder	0.000433	0.000555	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	0.000412	0.000527	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—EP300—conduct disorder	0.000407	0.000522	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—COMT—conduct disorder	0.000395	0.000506	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—MAOA—conduct disorder	0.000392	0.000503	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000381	0.000487	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—HTR2A—conduct disorder	0.00038	0.000486	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—DRD4—conduct disorder	0.000373	0.000477	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HTR2A—conduct disorder	0.000321	0.000411	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CGA—conduct disorder	0.000304	0.000389	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—COMT—conduct disorder	0.000302	0.000386	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—MAOA—conduct disorder	0.000299	0.000383	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—COMT—conduct disorder	0.000255	0.000327	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—MAOA—conduct disorder	0.000254	0.000325	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000246	0.000315	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HTR2A—conduct disorder	0.000243	0.000311	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—EP300—conduct disorder	0.000229	0.000294	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—COMT—conduct disorder	0.000222	0.000285	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—MAOA—conduct disorder	0.000221	0.000283	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—COMT—conduct disorder	0.000208	0.000266	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—MAOA—conduct disorder	0.000206	0.000264	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—EP300—conduct disorder	0.000201	0.000258	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.0002	0.000256	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—EP300—conduct disorder	0.00017	0.000218	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—EP300—conduct disorder	0.00017	0.000217	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—COMT—conduct disorder	0.000137	0.000176	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—MAOA—conduct disorder	0.000136	0.000174	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—EP300—conduct disorder	0.000129	0.000166	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—EP300—conduct disorder	0.000129	0.000165	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—EP300—conduct disorder	0.000109	0.00014	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—EP300—conduct disorder	9.54e-05	0.000122	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—EP300—conduct disorder	8.91e-05	0.000114	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—EP300—conduct disorder	5.88e-05	7.53e-05	CbGpPWpGaD
